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Abstract
Background: Sudden onset of bilateral blindness is rare; hysteria, cortical infarction or bilateral
central retinal arterial occlusion can cause this.
Case presentation: The authors describe a single case of sudden onset bilateral blindness in a
patient with nasopharyngeal carcinoma, which is unusual. Biopsy revealed a high-grade lymphoma.
After treatment the patient made a complete visual recovery, with no evidence of visual sequelae
and no clear reasons for this complete recovery.
Conclusion: CT and MR imaging did not demonstrate any lesions invading any part of the visual
pathway or even indeed the occipital cortex. High dose steroids may have reduced the mass effect
of the tumour or the blindness may have been hysterical but is unlikely.
Background
Nasopharyngeal carcinoma is one of the most common
cancers in eastern Asia. Usually presenting with a neck
mass and blood-tinged sputum [1,2]. Headache and cra-
nial nerve abnormalities have also been reported [3], pre-
sumably from brainstem involvement. With advanced
nasopharyngeal carcinoma the occurrence of distant
metastases are high [4]. Typical sites include bone, liver
and lung [5]. Brain metastasis is rare [6].
Case presentation
A 49-year-old female presented with an 18-hour history of
complete visual loss. The patient denied perception of
light. Six weeks prior to presentation the patient had com-
plained of nasal congestion. This was treated with nasal
steroid with no improvement. There were no other symp-
toms prior to her presentation.
On examination, both pupils were fixed and dilated.
Direct and consensual reflexes were absent (Amaurotic
pupils). Fundoscopy revealed a healthy retina with no
papilloedama or vessel engorgement. Further ocular
examination revealed roaming eye movements but no evi-
dence of cranial nerve involvement. Medically, the patient
was very distressed and could not cooperate to full exam-
ination. Urgent CT scan revealed a large nasopharyngeal
mass (60 mm diameter) extending from the level of the
base of the skull to approximately C2. The mass also
extended into the right sphenoidal sinus, left maxillary
sinus and bilateral nasal cavities.
A neoplastic lesion was suspected but with such wide-
spread parasinus involvement, infection could not be
excluded. The patient was given intravenous dexametha-
sone (16 mg) with 1.2 g Augmentin. Regular intravenous
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hydrocortisone (200 mg – 4 hourly) was commenced.
Preparations were made for theatre and urgent drainage of
the sinuses.
In theatre, a large, firm nasopharyngeal mass was noted in
the left and right nasal cavities extending from the post
nasal space to the posterior choanae. The mass was seen
to extend down to the level of the uvula in the oral cavity.
Biopsies were taken. There was no evidence of pus on
sphenoidotomy.
On day one post-operatively, perception of light was
denied. Both pupils were fixed and dilated. Day three post
operatively the patients' visual acuity suddenly improved
to 6/12 and the pupil reactions returned to normal. By day
four, vision had recovered to 6/5 and she was able to read
N5 print unaided. Goldmann visual field perimetry was
completely unremarkable and the patient scored fully on
Ishihara test plates.
Formal CT and MRI reports were obtained. Neither dem-
onstrated optic nerve/chiasm compression by mass or
associated fluid. The MRI report stated that several "high
density areas in the occipital cortex would account for the
patient's visual symptoms". Visual evoked potentials
(VEP) were conducted and found to be unremarkable.
However, there was no demonstrable field defect on full
Goldmann visual field screening. Histology of the mass
confirmed high-grade Non-Hodgkins lymphoma. Chem-
otherapy was commenced by the physicians and a cure
was anticipated.
Choroid metastasis from nasopharyngeal carcinoma has
previously been reported as a cause of visual disturbance
[7]. There have been two case reports of visual loss being
the initial presentation of nasopharyngeal carcinoma
[8,9]. These cases were reported as unilateral visual loss. In
either case, the CT scan demonstrated a space-occupying
lesion compromising the orbital apex area and there was
no improvement in vision, even after treatment [8]. A case
of cortical blindness associated with nasopharyngeal car-
cinoma has been previously reported [10]. In this case, the
patient had bilateral occipital lobe metastases causing per-
manent loss of vision. Blindness has also been reported as
a result of chemotherapy in treating nasopharyngeal carci-
noma [11].
Conclusion
The patient made a full visual recovery with no lasting vis-
ual field defect. This is testimony to the absence of optic
pathway or cortical involvement and worthy of note. The
mass effect of the tumour on the brain stem may explain
the patient's fixed dilated pupils, but not her blindness.
Invasion of the right sphenoidal sinus by the tumour may
have caused a localized visual field defect, but this proved
not to be so. The CT and MRI scans specifically reported
no optic chiasm involvement from tumour or associated
oedema. There was no evidence of occipital cortex infarct
or oedema on either CT/MRI scans. The intensive high-
dose steroids may have reduced the mass effect of the
tumour/oedema. The "blindness" may well have been
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